Holdings

Patient Square Capital LP

As of Sep 30, 2026, Patient Square Capital LP reported 22 positions worth US$601M. Largest: Roivant Sciences Ltd., Revolution Medicines, Inc. and United Therapeutics Corporation. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Roivant Sciences Ltd.7.71MUS$282M−310KSep 30, 2026
Revolution Medicines, Inc.196KUS$40.2M−80,000Sep 30, 2026
United Therapeutics Corporation62,677US$34M+25,557Sep 30, 2026
argenx SE28,000US$26.8M+5,000Sep 30, 2026
Abivax SA243KUS$24.1M+36,500Sep 30, 2026
Belite Bio, Inc.132KUS$22.4MnewSep 30, 2026
Mirum Pharmaceuticals, Inc.234KUS$20M−26,500Sep 30, 2026
Zai Lab Ltd.592KUS$15.6MnewSep 30, 2026
Definium Therapeutics, Inc.385KUS$14.7MnewSep 30, 2026
COMPASS Pathways Plc1.06MUS$13.1MnewSep 30, 2026